Algemeen Stedelijk Ziekenhuis Campus Aalst

At Algemeen Stedelijk Ziekenhuis Campus Aalst, clinical research in cardiovascular diseases focuses on reducing the burden of coronary artery disease, non-obstructive coronary artery disease, and atrial fibrillation-related stroke risk. These studies are designed to test new treatment strategies and improve prevention for people at elevated heart risk.

• Evaluating lipid-lowering therapies for people at high risk of heart attack and stroke
• Studying approaches to slow or reduce coronary plaque progression in coronary artery disease
• Assessing anticoagulation strategies to lower embolic events after atrial fibrillation treatment

This area of research aims to improve long-term cardiovascular protection and help identify better ways to prevent serious events before they occur.

Research in musculoskeletal diseases at this hospital includes peripheral spondyloarthritis, with a focus on finding more effective ways to bring inflammation under control and support remission. The work compares established treatment pathways with newer biologic-based approaches.

• Investigating treatment strategies for inflammatory joint disease
• Comparing conventional therapies with early biologic intervention
• Exploring options to improve symptom control and remission rates

The goal is to refine care for people with chronic inflammatory rheumatic conditions and improve outcomes through more targeted treatment choices.

Clinical trials in nutritional and metabolic diseases address obesity and type 2 diabetes, with a strong emphasis on weight management and metabolic health. These studies are testing whether new therapies can support weight loss and improve control of diabetes alongside lifestyle changes.

• Evaluating treatments for overweight and obesity in people with diabetes
• Studying therapies that may help improve weight and blood sugar control
• Supporting better cardiometabolic risk reduction through new treatment options

This research reflects growing interest in therapies that may help patients manage both excess weight and diabetes more effectively.

The virus diseases portfolio at Algemeen Stedelijk Ziekenhuis Campus Aalst includes studies in chronic hepatitis B infection. The research is focused on understanding treatment interruption and viral outcomes, with the broader aim of improving long-term management of this persistent infection.

• Examining outcomes after stopping antiviral treatment in chronic hepatitis B
• Investigating factors that may influence viral control over time
• Supporting better strategies for managing long-term hepatitis B care

This work is intended to help clarify which patients may benefit from different treatment approaches and to inform safer, more personalized care.